WebDisclosure WebDisclosure
Basculer en Français
9887 Companies
199029 Keywords
129968 Articles
105804 Press releases
Headlines Articles Press releases SANUWAVE Health, Inc. Remove
  1. Home
  2. Companies
  3. SANUWAVE Health, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/22/2024 at 14:09, 2 years ago

    SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)

    SANUWAVE Health, Inc. announces a special meeting of stockholders to vote on the business combination with SEP Acquisition Corp. The meeting is scheduled for February 21, 2024, to vote on the previously announced merger. SANUWAVE CEO Morgan Frank expresses excitement about the transaction, emphasizing its positive impact on the company's financial standing and future growth prospects. The company's focus on the research, development, and commercialization of patented, non-invasive medical systems for tissue repair and regeneration is also highlighted.
    SANUWAVE Health SEP Acquisition Corp Special Meeting Merger Proposal FDA-approved Wound Care Products
    Logo of SANUWAVE Health, Inc.
Accesswire
  • Published on 02/18/2026 at 15:15, 3 hours 33 minutes ago

    Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now

  • Published on 02/18/2026 at 15:00, 3 hours 48 minutes ago

    Jaguar Health Announces a Special One-time Stock Dividend

  • Published on 02/18/2026 at 14:25, 4 hours 23 minutes ago

    Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular

  • Published on 02/18/2026 at 14:00, 4 hours 48 minutes ago

    Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico

  • Published on 02/18/2026 at 14:00, 4 hours 48 minutes ago

    Datametrex Receives $1M Order from Fortune 500 Client

View all ACCESSWIRE
EQS Group
  • Published on 02/18/2026 at 18:21, 27 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 02/18/2026 at 18:00, 48 minutes ago

    E-PANGO : Décision du Tribunal administratif de Paris en date du 16 février 2026

  • Published on 02/18/2026 at 17:58, 50 minutes ago

    2CRSi SA: 2CRSi initiates, within the ÆTHER Infrastructure consortium, an exclusive negotiation for the establishment of a strategic industrial site dedicated to AI Gigafactories

  • Published on 02/18/2026 at 17:58, 50 minutes ago

    2CRSi SA: 2CRSi initie, au sein du consortium ÆTHER Infrastructure, une négociation exclusive pour l’implantation d’un site industriel stratégique dédié aux AI Gigafactories

  • Published on 02/18/2026 at 15:50, 2 hours 58 minutes ago

    CGTN: Private economy: A key actor in advancing China's economic priorities in 2026 and beyond

View all EQS
Les Echos
  • Published on 02/18/2026 at 18:00, 48 minutes ago

    Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 janvier 2026

  • Published on 02/18/2026 at 18:00, 48 minutes ago

    Outstanding Shares and Voting Rights Statement at 31 January 2026

  • Published on 02/18/2026 at 17:45, 1 hour 3 minutes ago

    Chiffre d'affaires annuelle

  • Published on 02/18/2026 at 17:40, 1 hour 8 minutes ago

    GROUPE ES - Communiqué sur les résultats 2025

  • Published on 02/18/2026 at 13:45, 5 hours 3 minutes ago

    NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy